Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma
BackgroundThe overall 5-year survival of lung cancer was reported to be only ~15%, with lung adenocarcinoma (LUAD) as the main pathological subtype. Before developing into invasive stages, LUAD undergoes pre-invasive stages of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA),...
Main Authors: | Yue Zhao, Jun Shang, Jian Gao, Han Han, Zhendong Gao, Yueren Yan, Qiang Zheng, Ting Ye, Fangqiu Fu, Chaoqiang Deng, Zelin Ma, Yang Zhang, Difan Zheng, Shanbo Zheng, Yuan Li, Zhiwei Cao, Leming Shi, Haiquan Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.921761/full |
Similar Items
-
Distribution and concordance of PD-L1 expression by routine 22C3 assays in East-Asian patients with non-small cell lung cancer
by: Fangqiu Fu, et al.
Published: (2022-11-01) -
Primary Tumor Resection Improves Survival for EGFR-TKI-Treated Patients With Occult M1a Lung Adenocarcinoma
by: Fangqiu Fu, et al.
Published: (2021-04-01) -
Tumor‐derived Vimentin as a novel biomarker for distinct subtypes predicting adjuvant chemotherapy resistance and T‐cell‐inflamed phenotype in small cell lung cancer
by: Chaoqiang Deng, et al.
Published: (2023-10-01) -
Uniportal versus multiportal video-assisted thoracoscopic anatomical resection for NSCLC: a meta-analysis
by: Yueren Yan, et al.
Published: (2020-09-01) -
Genomic and immune profiling of pre-invasive lung adenocarcinoma
by: Haiquan Chen, et al.
Published: (2019-11-01)